Search results
Emcure Pharma announces price band for Rs 1,952-crore IPO at Rs 960-1,008/share. Check GMP, other...
The Economic Times· 6 days agoEmcure Pharmaceuticals has set the price band for its upcoming initial public offering (IPO) at Rs...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 3 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
Emcure Pharma IPO: GMP rises sharply ahead of issue opening for subscription on July 3 - CNBC TV18
CNBC TV18· 5 days agoShares of Emcure Pharmaceuticals are trading at a premium of ₹270 in the unlisted market on Saturday...
Emucare Pharma sets price band of Rs 960-1008 a share for upcoming IPO
CNBC Awaaz· 7 days agoPune-based Emucare Pharmaceuticals has set a price band of Rs 960-1008 a share for its initial...
Emcure Pharmaceuticals IPO opens today | India Infoline
India Infoline· 1 day agoThe IPO, backed by Bain Capital, has a price band set between ₹960 and ₹1,008 per share and will close on July 5.
A New Page From Sidharth Malhotra's European Holiday - News18
News18· 5 days agoSidharth Malhotra recently treated his fans to a picturesque glimpse of his European holiday. In the...
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 2 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
7 best Jim Sarbh movies and web series that prove his versatility
Pinkvilla· 6 days agoCheck out Jim Sarbh's movies and web series that promise captivating storytelling and compelling...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 2 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
IPO Frenzy: 3 new issues and 11 listings to hit Dalal Street next week
CNBC Awaaz· 4 days agoThe primary market is gearing up for another stellar week as three companies are set to launch their...